Relationship between genetic polymorphism and disease, illustrated by means of the renin-angiotensin-aldosterone system and cardiovascular disease;Samenhang tussen genetische polymorfismen en ziekte geillustreerd aan het renine-angiotensine-aldosteronsysteem en cardiovasculaire aandoeningen

Nederlands Tijdschrift voor Geneeskunde

Volumn 142, Issue 25, 1998, Pages 1445-1450

  Spiering, W ^a   Kroon, A A ^a   Vreugdenhil, H A E ^b   Geraedts, J P M ^c   Daemen, M J A P ^b   De Leeuw, P W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Afd Molec Celbiologie en Genetica ^*

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC REGULATION; HYPERTENSION; MOLECULAR GENETICS; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANGIOTENSIN II; ANGIOTENSINOGEN; CARDIOVASCULAR DISEASES; CHROMOSOME MAPPING; FEMALE; GENETIC MARKERS; HUMANS; KIDNEY DISEASES; MALE; PEPTIDYL-DIPEPTIDASE A; POINT MUTATION; POLYMORPHISM, GENETIC; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; SPONDYLITIS, ANKYLOSING;

EID: 0032551127     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Pronk JC, Beemer FA, Geraedts JPM, Leschot NJ, Niermeijer MF. Medische genetica, 5e druk. Utrecht: Bunge, 1994.
2. Engelfriet CP, Geertzen HGM, Hack CE, Immunopathologie. In: Ottolander GJH den, redacteur. Interne geneeskunde. 10e druk. Houten: Bohn Stafleu Van Loghum, 1992:21-67.
3. Vries RRP de, Rood JJ van. Immunogenetics and disease. In: King RA, Rotter JI, Motulsky AG, editors. The genetic basis of common disease. New York: Oxford University Press, 1992:92-104.
4. Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991;324:1098-104.
5. Krekels MME. (Patho)physiology of the renin-angiotensin system. Relationships with sodium balance, Maastricht: Universiteit Maastricht, 1996.
6. Alhenc-Gelas F, Richard J, Courbon D, Warnet JM, Corvol P. Distribution of plasma angiotensin I-converting enzyme levels in healthy men: relationship to environmental and hormonal parameters. J Lab Clin Med 1991;117:33-9.
7. Cambien F, Alhenc-Gelas F, Herbeth B, Andre JL, Rakotovao R, Gonzales MF, et al. Familial resemblance of plasma angiotensinconverting enzyme level: the Nancy study. Am J Hum Genet 1988;43:774-80.
8. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G, et al Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA 1988;85:9386-90.
9. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, et al. Evidcnce. from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
10. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-4.
11. Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996;94:708-12.
12. Shanmugam V, Sell KW, Saha BK, Mistyping ACE heterozygotes. PCR Methods Appl 1993;3:120-1.
13. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997;15:1579-92.
14. Arbustini E, Grasso M, Leo G, Tinelli C, Fasani R, Diegoli M, et al. Polymorphism of angiotensin-converting enzyme gene in sarcoidosis. Am J Respir Crit Care Med 1996;153:851-4.
15. Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1904;24:63-9.
16. Davies E, Bonnardeaux A, Lathrop GM, Corvol P, Clauser E, Soubrier F, Angiotensin II (type-1) receptor locus: CA repeat polymorphism and genetic mapping. Hum Mol Genet 1994;3:838.
17. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidai P, Evans A, et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994;344:910-3.
18. Schmidt S, Beige J, Walla-Friedel M, Michel MC, Sharma AM, Ritz E. A polymorphism in the gene for the angiotensin II type 1 receptor is not associated with hypertension. J Hypertens 1997;15(12 Pt 1):1385-8
19. Tiret L, Blanc H, Ruidavets JB, Arveiler D, Lue G, Jeunemaitre X, et al. Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. J Hypertens 1998;16:37-44.
20. Benetos A, Topouchian J, Ricard S, Gautier S, Bonnardeaux A, Asmar R. et al. Influence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients. Hypertension 1995;26:44-7.
21. Doria A, Onuma T, Warram JH, Krolewski AS. Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM. Diabetologia 1997;40:1293-9.
22. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:169-80.
23. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994;330:1629-33.
24. Caulfield M, Lavender P, Newell-Price- J, Farrall M, Kamdar S, Daniel H, et al. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 1995; 96:687-92
25. Atwood LD, Kammerer CM, Samollow PB, Hixson JE, Shade RE, MacCluer JW Linkage of essential hypertension to the angiotensinogen locus in Mexican Americans. Hypertension 1997;30(3 Pt 1):326-30.
26. Walker WG, Whelton PK, Saito H, Russell RP, Hermann J. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1979;1:287-91.
27. Hegele RA, Brunt JH, Connelly PW. A polymorphism of the angiolensmogen gene associated with variation in blood pressure in a genetic isolate. Circulation 1994;90:2207-12.
28. Kamitani A, Rakugi H, Higaki J, Yi Z, Mikami H, Miki T, et al. Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens 1994;8: 521-4.
29. Iwai N, Shimoike H, Ohmichi N, Kinoshita M. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 1995;25(4 Pt 2):688-93.
30. Nishiuma S, Kario K, Kayaba K, Nagio N, Shimada K, Matsuo T, et al. Effect of the angiotensinogen gene Met235→Thr variant on blood pressure and other cardiovascular risk factors in two Japanese populations. J Hypertens 1995;13:717-22.
31. Schmidt S, Sharma AM, Zilch O, Beige J, Walla-Friedel M, Ganten D, et al. Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset, Nephrol Dial Transplant 1995;10:1145-8.
32. Jeunemaitre X, Inouo I, Williams C, Charru A, Tichet J, Powers M, et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997;60:1448-60.
33. Rotimi C, Morrison L, Cooper R, Oyejide C, Effiong E, Ladipo M, et al. Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans Hypertension 1994;24:591-4.
34. Kiema TR, Kauma H, Rantala AO, Lilja M, Reunanen A, Kesäniemi YA, et al. Variation at the angtotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension 1996;28:1070-5.
35. Ishigami T, Umemura S, Iwamoto T, Tamura K, Hibi K, Yamaguchi S, et al. Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation 1995;91:951-4.
36. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, et al. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 1993;4:59-61.
37. Sato N, Katsuya T, Rakugi H, Takami S, Nakata Y, Miki T, et al. Association of variants in critical core promoter element of angiotensinogen gene with increased risk of essential hypertension in Japanese. Hypertension 1997;30(3 Pt 1):321-5.
38. Doi Y, Yoshizumi H, Yoshinari M, lino K, Yamamoto M, Ichikawa K. et al. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 1996;39:97-102.
39. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-11.